Literature DB >> 15682661

Gastro-oesophageal reflux disease in Sudan: a clinical endoscopic and histopathological study.

H H M Ahmed1, H M Y Mudawi, S S Fedail.   

Abstract

This study was conducted to assess the frequency of gastroesophageal reflux disease (GERD) and Barrett's esophagus among Sudanese patients with clinical symptoms of heartburn. One hundred and five patients were included in the study; forty seven patients had evidence of reflux oesophagitis, 61.7% of whom had grade B oesophagitis according to the modified Los Angeles classification and 10.6% had Barrett's oesophagus. 78.7% of the biopsies from the esophageal cardia revealed presenced of inflammation (Carditis). Dysplasia was documented in 21.3% of these biopsies. Helicobacter pylori was detected 59.6% of gastrooesophageal reflux disease patients and 56.8% of patients with carditis. However, 80% of patients with Barrett oesophagus were positive for Helicobacter pylori. It was concluded that gastro-oesophageal reflux disease affects all age groups with males being affected more than females and Helicobacter pylori infection did not play a major role in gastro-oesophageal reflux disease orits complications.

Entities:  

Mesh:

Year:  2004        PMID: 15682661

Source DB:  PubMed          Journal:  Trop Gastroenterol        ISSN: 0250-636X


  2 in total

1.  Pattern of presentation of gastroesophageal reflux disease among patients with dyspepsia in Kano, Nigeria.

Authors:  Abubakar Sadiq Maiyaki; Musa Muhammed Borodo; Adamu Alhaji Samaila; Abdulmumini Yakubu
Journal:  Ann Afr Med       Date:  2017 Oct-Dec

Review 2.  Helicobacter pylori infection reduces the risk of Barrett's esophagus: A meta-analysis and systematic review.

Authors:  Bálint Erőss; Nelli Farkas; Áron Vincze; Benedek Tinusz; László Szapáry; András Garami; Márta Balaskó; Patrícia Sarlós; László Czopf; Hussain Alizadeh; Zoltán Rakonczay; Tamás Habon; Péter Hegyi
Journal:  Helicobacter       Date:  2018-06-25       Impact factor: 5.753

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.